Future TOC

Volume 27, Number 5 (October 2020)

Based on the author provided metadata and may not accurately reflect the final Table of Contents

Quality of life in a real-world study of metastatic colorectal cancer patients treated with trifluridine/tipiracil (FTD/TPI)
W. Y. Cheung, P. Kavan, A. Dolley

Prognostic utility of neutrophil-to-lymphocyte ratio in metastatic colorectal cancer patients treated with different modalities
G. Nogueira-Costa

Uncovid
H. S. Wald

A pan-Canadian prospective study of young women with breast cancer: The Rationale and Protocol Design for the RUBY study
M. L. Quan, I. Olivotto, N. Baxter, C. Friedenreich, K. Metcalfe, E. Warner, K. MacLennan, J. Stephen,
M. Akbari, D. Howell, S. Narod

A clinical investigation of the association between perioperative oral management and prognostic nutritional index in digestive and urinary cancer patients
S. Yamada

The Risk of Gastrointestinal Toxicity in Patients with Lung Cancer Treated with Immune-Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
K. Bishay, P. Tandon, S. Bourassa-Blanchette, S. A. Laurie, J. D. McCurdy

Delay in diagnosis of patients with head and neck cancer in Canada: impact of patient and provider delay
S. Kassirian, A. Dzioba, S. Hamel, K. Patel, D. Palma, N. Read, V. Venkatesan, A. Nichols, J. Yoo,
K. Fung, A. Mendez, S. D. MacNeil

The Prevention and Treatment of Cancer-associated Thrombosis
M. Carrier, S. Ng

Multicentric Chondrosarcoma Involving the Appendicular Skeleton: A Case Report and Literature Review
V. Aran, W. Meohas, A. C. de Sa Lopes, L. M. Cabral, A. F. Costa, J. A. M. Guimarães, M. E. L. Duarte

Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada
Y. Y. R. Li

Musculoskeletal oncology patients triage and management during COVID-19 pandemic
N. Olshinka, S. Mottard

Oncologists and Medical Assistance in Dying: Where do we stand?
O. Levine, S. Oczkowski, G. Pond, G. Chandhoke

Understanding clinical practice and survival outcomes in patients with stage III, unresectable non-small cell lung cancer in a single-centre in Quebec, Canada
G. Kasymjanova, J. S. Agulnik, C. Pepe, M. Hurry, R. N. Walton, L. Sakr, V. Cohen, M. Lecavalier,
D. Small

Improving Formative Assessments in Canadian Medical Oncology Residency Training
R. Arora, S. D. Mukherjee

Osteopontin Level and Promoter Polymorphism in Egyptian Metastatic Breast Cancer Patients
M. A. Elbaiomy, T. Akl, W. El-Beshbishi, R. Elhelaly, R. Elzehery, M. El-Ghonemy

Delaying strategies to surgery for the management of resectable hepato-biliary malignancies during the COVID-19 pandemic
S. Bennett, K. Soreide, S. Gholami, P. Pessaux, C. Teh, E. Segelov, H. Kennecke, H. Prenen, S. Myrehaug, D. Callegaro, J. Hallet

Nodal staging impacts adjuvant treatment choices in elderly patients with clinically node negative, estrogen receptor positive breast cancer
A. Laws, R. Cheifetz, R. Warburton, C. E. McGahan, J. S. Pao, U. Kuusk, C. Dingee, M. L. Quan,
E. McKevitt

Diagnostic Patterns of Non-Small Cell Lung Cancer at Princess Margaret Cancer Centre
M. Nadjafi, M. Sung, G. da Cunha Santos, L. Le, D. Hwang, M. Tsao, N. Leighl

 


Upcoming in Current Oncology

Hematology oncology clinicians’ perspectives on integrating palliative care in oncology
R. Booker, S. Dunn, M. Earp, A. Sinnarajah, P. Biondo, J. Simon

Canadian guidelines on the management of colorectal peritoneal metastases
A. Brind'Amour, P. Dubé, J.F. Tremblay, M. Soucisse, L. Mack, A. Bouchard-Fortier, A. McCart, A. Govindarajan, D. Bischof, E. Haase, C. Giacomantonio, P. Hebbard, R. Younan, A. MacNeill, C. Boulanger-Gobeil, L. Sidéris

Code status communication training in postgraduate oncology programs: a needs assessment
O. Levine, S. Dhesy-Thind, M. McConnell, M. Brouwers, S. Mukherjee

Prognostic Ability of PD-L1 Levels in Urothelial Carcinoma Patients– A meta-analysis
J. Huang, X. Teng

Economic evaluation of adjuvant trastuzumab emtansine in HER2-positive early breast cancer patients with residual invasive disease following neoadjuvant taxane and trastuzumab-based treatment in Canada
T. Younis, A. Lee, M. E. Coombes, N. Bouganim, D. Becker, C. Revil, G. S. Jhuti

Longitudinal health utilities, symptoms and toxicities in Anaplastic Lymphoma Kinase (ALK) rearranged lung cancer patients treated with tyrosine kinase inhibitors: A prospective, real world assessment
B. C. Tse, B. I. Said, Z. J. Fan, K. Hueniken, D. Patel, G. Gill, M. Liang, M. Razooqi, M. C. Brown, A. G. Sacher, P. A. Bradbury, F. A. Shepherd, N. B. Leighl, W. Xu, D. Howell, G. Liu, G. O'Kane

Primary care use following cancer treatment: an analysis of linked administrative data
R. Urquhart, L. Lethbridge

Lysine analogue use during cancer surgery: a survey from a Canadian tertiary care centre
R. H. Breau

First-line therapy, autologous stem cell transplantation, and post-transplant maintenance in the management of patients newly diagnosed with mantle cell lymphoma
N. Varela, S. Bhella, M. Cheung, G. Fraser, M. Crump, A. Aw, C. Bredeson, T. Kouroukis, S. Sajkowski

A Population-based Study of Pulmonary Monitoring and Toxicity for Patients with Testicular Cancer Treated with Bleomycin
M. Raphael

BTK Inhibitors for the frontline treatment of chronic lymphocytic leukemia
V. Banerji, A. Aw, S. Robinson, S. Doucette, A. Christofides, L. Sehn

Comprehensive genomic profiling for non-small cell lung cancer: health and budget impact
K. M. Johnston, B. Sheffield, S. Yip, P. Lakzadeh, C. Qian, J. Nam

Presenting stage and risk group in men dying of prostate cancer
S. Parimi, S. Bondy, M. Aparicio, K. Sunderland, J. Cho, F. Bachand, K. N. Chi, T. Pickles, S. Tyldesley

The cost of failed first-line cancer treatment due to continued smoking in Canada
N. Iragorri, B. Essue, C. Timmings, D. Keen, H. Bryant, G. Warren

Clinicopathological characteristics, survival and treatments in adenosquamous carcinoma of the stomach: a population-based study
H. Li, M. Zhang, K. Cheng, Y. Chen, Y. Zhou, J. Liu

A systematic review and network meta-analysis of second-line therapy in hepatocellular carcinoma
S. D. Santos, S. Udayakumar, A. Nguyen, Y. Ko, S. Berry, M. Doherty, K. KW. Chan